Johnson & Weaver, Announces Investigations of Omega Protein Corporation, Monogram Residential Trust, Inc. and Akorn, Inc.; Investors Encouraged to Contact Firm

SAN DIEGO, July 7, 2017 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential claims against Omega Protein Corporation, Monogram Residential Trust, Inc., and Akorn, Inc. as detailed below:

Omega Protein Corporation

Shareholder Rights Law Firm Johnson & Weaver, LLP today announced that it is investigating whether certain officers or directors of Omega Protein Corporation OME ("Omega") violated federal or state laws.

Earlier in 2017, a Securities Class Action Complaint was filed on behalf of those who purchased securities of Omega. The Complaint states that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that the SEC had requested information for an investigation relating to Omega's subsidiary's compliance with its probation terms and Omega's protection of whistleblower employees. 

If you are a long-term shareholder of Omega shares and continuously held shares before August 3, 2016, you may have standing to hold Omega harmless from the damage the officers and directors may have caused by making them personally responsible. You may also be able to assist in reforming the Company's corporate governance to prevent future wrongdoing.

If you are a long-term Omega shareholder and are interested in learning more about your legal rights and remedies, please contact Jim Baker (jimb@johnsonandweaver.com) at 619-814-4471. If you email, please include your phone number.

Monogram Residential Trust, Inc.

Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Monogram Residential Trust, Inc. MORE ("Monogram") breached their fiduciary duties in connection with the proposed sale of the Company to Greystar Growth and Income Fund, LP ("Greystar").

On July 4, 2017, Monogram announced that it had signed a definitive merger agreement with Greystar. Terms of the deal call for shareholders to receive $12 per share for each share of Monogram stock they own.

The investigation concerns whether the Monogram board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Monogram shares of common stock. Nationally recognized Johnson & Weaver is investigating whether the proposed deal price represents adequate consideration.

If you are a shareholder of Monogram and believe the proposed buyout price is too low or you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (jimb@johnsonandweaver.com) at 619-814-4471.

Akorn, Inc.

Shareholder Rights Law Firm Johnson & Weaver, LLP announced that a class action lawsuit has been filed on behalf of purchasers of Akorn, Inc. AKRX ("Akorn") in connection with the proposed sale of the Company to German-based Fresenius Kab.

On April 24, 2017, Akorn revealed that it had signed a definitive merger agreement with Fresenius Kabi. Under the terms of the agreement, Akorn shareholders will receive $34 in cash for each share of common stock held.

The Complaint alleges that the Proxy Statement recommended that Akorn shareholders vote in favor of the proposed transaction without disclosing important information necessary for shareholders to make an informed decision.  The Proxy Statement omitted key facts about Akorn's financial projections, the analysis performed by Akorn's financial advisor, and the background of the proposed transaction. The Complaint seeks relief and damages on behalf of Akorn common stock shareholders. 

If you are an Akorn shareholder and are interested in learning more about your legal rights and remedies, please contact Jim Baker (jimb@johnsonandweaver.com) at 619-814-4471. If you email, please include your phone number.

About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
jimb@johnsonandweaver.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/johnson--weaver-announces-investigations-of-omega-protein-corporation-monogram-residential-trust-inc-and-akorn-inc-investors-encouraged-to-contact-firm-300484798.html

SOURCE Johnson & Weaver, LLP